# ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - SEPTEMBER 25, 2023. TASK O

> **NIH NIH N01** · LOVELACE BIOMEDICAL RESEARCH INSTITUTE · 2022 · $102,721

## Abstract

The objectives of this project are to determine the effects of experimental compounds on respiratory parameters in rodents or other species in models relevant to the opioid overdose crisis. Compounds may be tested alone for effects on respiration (stimulation or depression), or for their ability to modulate respiratory depressant effects of opioids and possibly other drugs of abuse.

## Key facts

- **NIH application ID:** 10713095
- **Project number:** 75N95022D00019-0-759502200003-1
- **Recipient organization:** LOVELACE BIOMEDICAL RESEARCH INSTITUTE
- **Principal Investigator:** FADI XU
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $102,721
- **Award type:** —
- **Project period:** 2022-09-26 → 2023-09-25

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10713095

## Citation

> US National Institutes of Health, RePORTER application 10713095, ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - SEPTEMBER 25, 2023. TASK O (75N95022D00019-0-759502200003-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10713095. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*